Shicai Chen

Dr. Shicai Chen


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
HWHaishaerjiang Wushouer
Haishaerjiang Wushouer
Kexin DuKexin Du
Kexin Du
SCShicai Chen
Shicai Chen
YZYue Zhou
Yue Zhou
BZBo Zheng
Bo Zheng
Luwen ShiLuwen Shi
Luwen Shi
(1) Background: Few studies have focused on antibiotic use and appropriateness in children in primary health institutions (PHIs). This study aimed to identify the patterns and appropriateness of antibiotic use for children in PHIs in Beijing, China. (2) Methods: Outpatient prescriptions of 327 PHIs from 2017 to 2019 for patients <18 years old were collected. Prescriptions were described using quantity indicators. Antibiotics were categorized according to ATC classification J01 and Access, Watch, Reserve grouping. Appropriateness was reviewed by experts using three subtypes of irrational prescriptions (irregular, inappropriate, and abnormal). (3) Results: 20,618 prescriptions were collected in total. The antibiotic prescription rate (APR) was 15.1% (N = 3113). Among antibiotic prescriptions, J01FA Macrolides were the most used (N = 1068, 34.9%). The Watch group constituted 89.0% (N = 2818) of total antibiotic use. Bronchitis (N = 1059, 35.2%) was the most common diagnosis. A total of 292 instances of irrational antibiotic use were identified, with inappropriate prescriptions being the most prevalent subtype (N = 233, 79.8%). (4) Conclusion: Although APR for children in PHIs in Beijing was relatively low, the pattern of antibiotic use differed from other countries. Further studies are needed to optimize antibiotic use for children in PHIs under different levels of economic development.

1 October 2018 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
BXBinbin Xia
Binbin Xia
YLYali Li
Yali Li
YZYatong Zhang
Yatong Zhang
MXMing Xue
Ming Xue
XLXiaorong Li
Xiaorong Li
SCShicai Chen
Shicai Chen

8 October 2025 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
YZYing Zhang
Ying Zhang
YZYing Zhao
Ying Zhao
JCJun Cai
Jun Cai
LNLei Niu
Lei Niu
XZXiaozhu Zhou
Xiaozhu Zhou
XCxiangli Cui
xiangli Cui
Caprini score, the most commonly used assessment tool for predicting postoperative venous thromboembolism (VTE) risk has shown poor predictive value in colorectal cancer surgery. Recent risk assessment models (RAMs) Sir-Run-Run-Shaw VTE RAM, Risk of Venous Thromboembolism Algorithm (RVTA) score, and Colorectal Cancer - Venous Thromboembolism (CRC-VTE) score, which were specific for colorectal cancer, were developed and had good VTE predictive performance. We sought to externally validate for their generalizability and accuracy in Chinese patients undergoing colorectal cancer surgery. A retrospective analysis was conducted to predict the 6-month postoperative VTE risk in patients undergoing colorectal cancer surgery from January 2020 to December 2023. Demographic characteristics, clinical data, and 6-month postoperative VTE status of the patients were collected based on Sir-Run-Run-Shaw VTE RAM, RVTA score, CRC-VTE score, and Caprini score. We estimated the four VTE RAMs’ discrimination of 6-month postoperative VTE risk by using the area under the receiver operating characteristic curve (AUROC). Calibration plots, Hosmer-Lemeshow test, and decision curve analysis were also explored to assess the predictive performance of the four VTE RAMs. A total of 323 patients were included. The median age of our cohort was 66 years (range, 58–73 years), and 182 (56.3%) patients were male. VTE occurred in 68 (21.1%) cases within 6 months after operation, with 5 cases of pulmonary embolism and 63 cases of deep vein thrombosis, of which 45 (66.2%) cases experienced VTE within 4 weeks after operation. Sir-Run-Run-Shaw VTE RAM, RVTA score, CRC-VTE score and Caprini score demonstrated possibly helpful discrimination, with AUCs of 0.691 (95%CI: 0.624–0.758), 0.638 (95%CI: 0.564–0.713), 0.728 (95%CI: 0.663–0.793), and 0.661 (95%CI: 0.596–0.725), respectively. The Hosmer-Lemeshow test indicated a lack of fit for Sir-Run-Run-Shaw VTE RAM, RVTA score, and CRC-VTE score (P < 0.05). Furthermore, decision curve analysis revealed that CRC-VTE score provided greater net benefits than the other VTE RAMs. External validation of the four VTE RAMs for predicting postoperative VTE in a real-world cohort of colorectal cancer patients showed that CRC-VTE score outperformed the other VTE RAMs. It can help clinicians identify patients with high risk of VTE, thereby facilitating timely prophylactic interventions and close monitoring. • 68 (21.1%) patients experienced VTE events within 6 months after colorectal cancer surgery, including 5 cases of PE and 63 cases of DVT. • CRC-VTE score had an AUC of 0.728 (95%CI: 0.663–0.793), which was higher than the AUCs of the other VTE RAMs. • The results of the comprehensive model discrimination, calibration, and clinical utility showed that CRC-VTE score outperformed the other VTE RAMs. It can identify patients with high risk of VTE and guide appropriate thromboprophylaxis.